THESEUS PHARMACEUTICALS INC's ticker is and the CUSIP is 88369M101. A total of 48 filers reported holding THESEUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,031 | -100.0% | 755 | -99.9% | 0.00% | -100.0% |
Q2 2023 | $7,516,631 | -62.0% | 805,641 | -63.8% | 0.00% | 0.0% |
Q1 2023 | $19,778,638 | +59.0% | 2,227,324 | -10.8% | 0.00% | 0.0% |
Q4 2022 | $12,441,808 | -55.3% | 2,498,355 | -48.0% | 0.00% | -66.7% |
Q3 2022 | $27,859,000 | -2.8% | 4,803,240 | -7.3% | 0.00% | 0.0% |
Q2 2022 | $28,664,000 | -55.3% | 5,183,363 | -6.7% | 0.00% | -40.0% |
Q1 2022 | $64,077,000 | -7.3% | 5,557,447 | +2.0% | 0.01% | 0.0% |
Q4 2021 | $69,089,000 | – | 5,448,669 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management V, LLC | 3,212,732 | $40,737,000 | 10.01% |
Lynx1 Capital Management LP | 409,358 | $5,191,000 | 4.53% |
Foresite Capital Opportunity Management V, LLC | 468,820 | $5,945,000 | 3.99% |
Orbimed Advisors | 16,838,668 | $213,514,000 | 2.74% |
Nextech Invest Ltd. | 611,310 | $7,751,000 | 2.04% |
Omega Fund Management, LLC | 711,479 | $9,022,000 | 1.28% |
Boxer Capital, LLC | 892,057 | $11,311,000 | 0.44% |
DAFNA Capital Management LLC | 97,500 | $1,236,000 | 0.31% |
Rock Springs Capital Management LP | 437,329 | $5,545,000 | 0.13% |
Woodline Partners LP | 250,000 | $3,170,000 | 0.04% |